2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals
- PMID: 20396549
- PMCID: PMC2855096
- DOI: 10.4143/crt.2004.36.2.103
2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals
Abstract
Purpose: To estimate the number of cancer cases during 2002 in Korea through a nationwide hospital based cancer registration by the Korea Central Cancer Registry (KCCR).
Materials and methods: One hundred and thirty nine hospitals participated in the KCCR program in 2002. Cancer cases were coded and classified according to the International Classification of Diseases for Oncology 2(nd) edition (ICD-O-2). The software program "IARC Check" was used to evaluate the quality of registered cancer cases. Of the 122,770 malignancies registered, 11,732 (9.6%) duplicated malignancies were excluded. Among the remaining 102,677 malignancies, 3,652 (3.6%) cases with carcinoma in situ (Morphology code/2) were separated. Finally, 99,025 malignancies were analyzed.
Results: Of the total of 99,025 malignancies, 55,398 (55.9%) cases were males and 43,627 (44.1%) were females. More than one third of cases were from the elderly (65 years old and more). The six leading primary cancer sites in the order of their relative frequency, were stomach (24.0%), followed by the lung (16.0%), the liver (15.4%), the colorectum (11.6%), the bladder (3.2%), and the prostate (3.0%) among males. In females, the breast (16.8%) was the common cancer site, followed by the stomach (15.3%), the colorectum (10.7%), the thyroid gland (9.5%), the cervix uteri (9.1%), and the lung (6.6%).
Conclusion: With the continued increase in cancer cases especially prostate cancer among males and thyroid cancer among females, the total number of registered cancer cases in Korea continues to rapidly increase.
Keywords: Annual report; Cancer registry.
Figures
Similar articles
-
2001 annual report of the Korea Central Cancer Registry: based on registered data from 134 hospitals.Cancer Res Treat. 2004 Feb;36(1):19-30. doi: 10.4143/crt.2004.36.1.19. Epub 2004 Feb 29. Cancer Res Treat. 2004. PMID: 20396562 Free PMC article.
-
Annual Report of the Central Cancer Registry in Korea-1999: Based on Registered Data from 128 Hospitals.Cancer Res Treat. 2001 Oct;33(5):367-72. doi: 10.4143/crt.2001.33.5.367. Cancer Res Treat. 2001. PMID: 26680809
-
Annual Report of the Korea Central Cancer Registry Program 2000: Based on Registered Data from 131 Hospitals.Cancer Res Treat. 2002 Apr;34(2):77-83. doi: 10.4143/crt.2002.34.2.77. Cancer Res Treat. 2002. PMID: 26680846
-
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
-
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1. Epub 2019 Oct 14. J Insur Med. 2019. PMID: 31609640
Cited by
-
A phase II study of leucovorin, 5-FU and docetaxel combination chemotherapy in patients with inoperable or postoperative relapsed gastric cancer.Cancer Res Treat. 2008 Mar;40(1):11-5. doi: 10.4143/crt.2008.40.1.11. Epub 2008 Mar 31. Cancer Res Treat. 2008. PMID: 19688059 Free PMC article.
-
A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome.J Hum Genet. 2004;49(11):591-595. doi: 10.1007/s10038-004-0193-9. Epub 2004 Sep 10. J Hum Genet. 2004. PMID: 15368100
-
Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma.Br J Cancer. 2006 May 22;94(10):1402-6. doi: 10.1038/sj.bjc.6603133. Br J Cancer. 2006. PMID: 16641896 Free PMC article. Clinical Trial.
-
A multi-center, phase ii clinical trial of Padexol (paclitaxel) and cisplatin for patients suffering with advanced gastric cancer.Cancer Res Treat. 2005 Dec;37(6):349-53. doi: 10.4143/crt.2005.37.6.349. Epub 2005 Dec 31. Cancer Res Treat. 2005. PMID: 19956371 Free PMC article.
-
Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.Cell Oncol (Dordr). 2011 Feb;34(1):45-54. doi: 10.1007/s13402-010-0004-6. Epub 2011 Feb 2. Cell Oncol (Dordr). 2011. PMID: 21290211
References
-
- 2002 Annual report of Korea Central Cancer Registry (published in 2003) Ministry Health and Welfare. Available from URL: http://www.ncc.re.kr.
-
- WHO IARC. Cancer Registration; Principles and methods. Lyon, France: 1991.
-
- Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, Ohrr HC, Ahn DH, Ferlay J, Parkin DM, Oh DK, Park JG. Cancer Incidence in Korea. Cancer Res Treat. 2002;34:405–408. - PubMed
-
- WHO IARC. Cancer Incidence in Five Continents. 2002;Volume VIII - PubMed
LinkOut - more resources
Full Text Sources